Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment

We here present the study results of 21 HIV-1 infected children who were treated with indinavir plus low-dose ritonavir and two nucleoside reverse transcriptase inhibitors (NRTIs) for 48 weeks. Although this q12h HAART regimen had potent antiretroviral activity, it was frequently associated with sid...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraaij, P. L. A., Verweel, G., van Rossum, A. M. C., Hartwig, N. G., Burger, D. M., de Groot, R.
Formato: Texto
Lenguaje:English
Publicado: Urban & Vogel 2007
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782124/
https://www.ncbi.nlm.nih.gov/pubmed/17565462
http://dx.doi.org/10.1007/s15010-007-6068-1
_version_ 1782174606019264512
author Fraaij, P. L. A.
Verweel, G.
van Rossum, A. M. C.
Hartwig, N. G.
Burger, D. M.
de Groot, R.
author_facet Fraaij, P. L. A.
Verweel, G.
van Rossum, A. M. C.
Hartwig, N. G.
Burger, D. M.
de Groot, R.
author_sort Fraaij, P. L. A.
collection PubMed
description We here present the study results of 21 HIV-1 infected children who were treated with indinavir plus low-dose ritonavir and two nucleoside reverse transcriptase inhibitors (NRTIs) for 48 weeks. Although this q12h HAART regimen had potent antiretroviral activity, it was frequently associated with side effects and discontinuation of therapy.
format Text
id pubmed-2782124
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Urban & Vogel
record_format MEDLINE/PubMed
spelling pubmed-27821242009-11-30 Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment Fraaij, P. L. A. Verweel, G. van Rossum, A. M. C. Hartwig, N. G. Burger, D. M. de Groot, R. Infection Brief Report We here present the study results of 21 HIV-1 infected children who were treated with indinavir plus low-dose ritonavir and two nucleoside reverse transcriptase inhibitors (NRTIs) for 48 weeks. Although this q12h HAART regimen had potent antiretroviral activity, it was frequently associated with side effects and discontinuation of therapy. Urban & Vogel 2007-06 /pmc/articles/PMC2782124/ /pubmed/17565462 http://dx.doi.org/10.1007/s15010-007-6068-1 Text en © Urban & Vogel München 2007
spellingShingle Brief Report
Fraaij, P. L. A.
Verweel, G.
van Rossum, A. M. C.
Hartwig, N. G.
Burger, D. M.
de Groot, R.
Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment
title Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment
title_full Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment
title_fullStr Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment
title_full_unstemmed Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment
title_short Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Treatment
title_sort indinavir/low-dose ritonavir containing haart in hiv-1 infected children has potent antiretroviral activity, but is associated with side effects and frequent discontinuation of treatment
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782124/
https://www.ncbi.nlm.nih.gov/pubmed/17565462
http://dx.doi.org/10.1007/s15010-007-6068-1
work_keys_str_mv AT fraaijpla indinavirlowdoseritonavircontaininghaartinhiv1infectedchildrenhaspotentantiretroviralactivitybutisassociatedwithsideeffectsandfrequentdiscontinuationoftreatment
AT verweelg indinavirlowdoseritonavircontaininghaartinhiv1infectedchildrenhaspotentantiretroviralactivitybutisassociatedwithsideeffectsandfrequentdiscontinuationoftreatment
AT vanrossumamc indinavirlowdoseritonavircontaininghaartinhiv1infectedchildrenhaspotentantiretroviralactivitybutisassociatedwithsideeffectsandfrequentdiscontinuationoftreatment
AT hartwigng indinavirlowdoseritonavircontaininghaartinhiv1infectedchildrenhaspotentantiretroviralactivitybutisassociatedwithsideeffectsandfrequentdiscontinuationoftreatment
AT burgerdm indinavirlowdoseritonavircontaininghaartinhiv1infectedchildrenhaspotentantiretroviralactivitybutisassociatedwithsideeffectsandfrequentdiscontinuationoftreatment
AT degrootr indinavirlowdoseritonavircontaininghaartinhiv1infectedchildrenhaspotentantiretroviralactivitybutisassociatedwithsideeffectsandfrequentdiscontinuationoftreatment

Ejemplares similares